|Articles|October 1, 2003
- Pharmaceutical Executive-10-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
almost 23 years ago
Balanced Scorecard for R&Dalmost 23 years ago
Pharma's Value Propositionalmost 23 years ago
Sharing IP, Sharing RiskAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5